Back to top

rsi: Archive

Zacks Equity Research

Anika (ANIK) Loses -19.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Anika (ANIK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ANIKNegative Net Change

Zacks Equity Research

Down -24.75% in 4 Weeks, Here's Why You Should You Buy the Dip in Athira Pharma, Inc. (ATHA)

Athira Pharma, Inc. (ATHA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ATHANegative Net Change

Zacks Equity Research

Down -40.31% in 4 Weeks, Here's Why Lemonade (LMND) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Lemonade (LMND) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

LMNDPositive Net Change

Zacks Equity Research

Down -26.93% in 4 Weeks, Here's Why BioVie Inc. (BIVI) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for BioVie Inc. (BIVI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

BIVIPositive Net Change

Zacks Equity Research

Down -27.71% in 4 Weeks, Here's Why You Should You Buy the Dip in 3D Systems (DDD)

The heavy selling pressure might have exhausted for 3D Systems (DDD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

DDDPositive Net Change

Zacks Equity Research

Down -9.64% in 4 Weeks, Here's Why You Should You Buy the Dip in Atyr Pharma (LIFE)

Atyr Pharma (LIFE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

LIFEPositive Net Change

Zacks Equity Research

Sera Prognostics, Inc. (SERA) Loses -38.49% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Sera Prognostics, Inc. (SERA) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

SERANegative Net Change

Zacks Equity Research

Down -17.83% in 4 Weeks, Here's Why Model N (MODN) Looks Ripe for a Turnaround

Model N (MODN) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

MODNPositive Net Change

Zacks Equity Research

Down -29.51% in 4 Weeks, Here's Why 3D Systems (DDD) Looks Ripe for a Turnaround

3D Systems (DDD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

DDDPositive Net Change

Zacks Equity Research

Down -20.42% in 4 Weeks, Here's Why Sonos (SONO) Looks Ripe for a Turnaround

Sonos (SONO) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

SONOPositive Net Change

Zacks Equity Research

Down -43.44% in 4 Weeks, Here's Why Lemonade (LMND) Looks Ripe for a Turnaround

Lemonade (LMND) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

LMNDPositive Net Change

Zacks Equity Research

Ulta (ULTA) Loses -7.63% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Ulta (ULTA) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ULTAPositive Net Change

Zacks Equity Research

Down -7.76% in 4 Weeks, Here's Why Tetra (TTEK) Looks Ripe for a Turnaround

Tetra (TTEK) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

TTEKPositive Net Change

Zacks Equity Research

Down -29.2% in 4 Weeks, Here's Why You Should You Buy the Dip in BioVie Inc. (BIVI)

BioVie Inc. (BIVI) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

BIVIPositive Net Change

Zacks Equity Research

Down -26.16% in 4 Weeks, Here's Why Allegro MicroSystems, Inc. (ALGM) Looks Ripe for a Turnaround

Allegro MicroSystems, Inc. (ALGM) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

ALGMNegative Net Change

Zacks Equity Research

Down -16.95% in 4 Weeks, Here's Why Commercial Vehicle Group (CVGI) Looks Ripe for a Turnaround

Commercial Vehicle Group (CVGI) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CVGIPositive Net Change

Zacks Equity Research

After Plunging -11.63% in 4 Weeks, Here's Why the Trend Might Reverse for Crocs (CROX)

Crocs (CROX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

CROXPositive Net Change

Zacks Equity Research

Model N (MODN) Loses -18.52% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Model N (MODN) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

MODNPositive Net Change

Zacks Equity Research

Down -32.13% in 4 Weeks, Here's Why You Should You Buy the Dip in PowerFleet (PWFL)

PowerFleet (PWFL) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

Zacks Equity Research

Down -6.07% in 4 Weeks, Here's Why Federal Signal (FSS) Looks Ripe for a Turnaround

Federal Signal (FSS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

FSSPositive Net Change

Zacks Equity Research

Five Below (FIVE) Loses -12.57% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Five Below (FIVE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

FIVEPositive Net Change

Zacks Equity Research

CytomX Therapeutics (CTMX) Loses -13.45% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for CytomX Therapeutics (CTMX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CTMXPositive Net Change

Zacks Equity Research

Down -20.21% in 4 Weeks, Here's Why PDF Solutions (PDFS) Looks Ripe for a Turnaround

PDF Solutions (PDFS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

PDFSNegative Net Change

Zacks Equity Research

Down -23.45% in 4 Weeks, Here's Why You Should You Buy the Dip in BioVie Inc. (BIVI)

The heavy selling pressure might have exhausted for BioVie Inc. (BIVI) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

BIVIPositive Net Change

Zacks Equity Research

Down -14.72% in 4 Weeks, Here's Why Marchex (MCHX) Looks Ripe for a Turnaround

The heavy selling pressure might have exhausted for Marchex (MCHX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

MCHXNegative Net Change